Phenolic Compounds May Explain Mediterranean Diet Benefits
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study.
Lipoic Acid (ALA) Could Reduce Atherosclerosis, Weight Gain
A new study has discovered that supplements of lipoic acid can inhibit formation of arterial lesions, lower triglycerides, and reduce blood vessel inflammation and weight gain - all key issues for addressing cardiovascular disease.
Task Force Issues Two Recommendations on Screening for Diabetes in Adults and Pregnant Women
The U.S. Preventive Services Task Force recommended that adults with high blood pressure or high cholesterol be screened for Type 2 diabetes.
Key Fat and Cholesterol Cell Regulator Identified, Promising Target
Researchers have identified how a molecular switch regulates fat and cholesterol production, a step that may help advance treatments for metabolic syndrome, the constellation of diseases that includes high cholesterol, obesity, type II diabetes, and high blood pressure.
Diabetes Medication May Help Slow Plaque Build-up in Coronary Arteries
A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA.
Study Shows Patients Taking Lipitor Show Significant Cardiovascular Benefit
Preliminary results showed diabetic patients who took the cholesterol-lowering medicine Lipitor had significantly fewer heart attacks, strokes and surgical procedures compared to patients who received placebo.
Researcher Breaks Down Cholesterol Mystery
Scientist: chylomicrons gather on arterial walls and may be as dangerous or more dangerous than low-density lipoprotein (LDL) cholesterol in causing strokes and heart attacks.
Cooking Oil to Fight Fat and Cholesterol?
Study of new blend of cooking oil that enables people to heighten their metabolism, lower their cholesterol and, in some cases, lose weight.
False Sense of Security Among Statin Users Leading to Heart Disease and Illnesses
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
NCEP Updates Guidelines For Treatment Of Blood Cholesterol
NCEP suggests that people at risk for heart attack and stroke would benefit from more intensive cholesterol-lowering therapies.
Extended-Release Niacin Effective in Low Doses for Diabetics
Niacin, a medication once discouraged for the treatment of lipid abnormalities in patients with diabetes, has the potential ability, when given in low doses, to be well-tolerated and effective.
Statin Therapy Cuts Bad Cholesterol Unprecedented 70-Percent
Research shows that a combination statin therapy lowers bad cholesterol by an unprecedented 70 percent, and has the added benefit of reducing life-threatening inflammation that can lead to heart disease and stroke.
Researchers Link Red Wine to Good Cholesterol
Researchers in France have found differences in red wine drinkers' good cholesterol, which could account for the drink's beneficial effects against cardiovascular disease.
Possible Mechanism For Link Between Diabetes and Alzheimer’s Disease Discovered
Insulin resistance in brain cells can affect how they function, causing some of the biochemical changes typically seen in Alzheimer's disease.
Men May Be at Increased Risk of Peripheral Artery Disease When They Have Certain...
Among nearly 45,000 men who were followed up for more than two decades, those with the risk factors of smoking, hypertension, high cholesterol, and type 2 diabetes had an associated greater risk of developing PAD.
Fructose-Sweetened Drinks Increase Nonfasting Triglycerides in Obese Adults
Obese people who drink fructose-sweetened beverages with their meals have an increased rise of triglycerides following the meal, according to new research.


